Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Strengthening the Evidence for Policy on the RTS,S/AS01 Malaria Vaccine — Stella

View on ClinicalTrials.gov

Recruiting

Back to Malaria trials

Trial locations(4 sites)

Ghana

Kintampo Health Research Centre, Kintampo

Kenya

African Research Collaboration for Health Limited, Nairobi

Kenya Medical Research Institute (KEMRI), Nairobi

Malawi

College of Medicine, University of Malawi, Blantyre

Key details

Sponsor

Kintampo Health Research Centre, Ghana

Collaborators

European Vaccine Initiative, London School of Hygiene and Tropical Medicine

Enrollment target

~9,280 participants

Started

October 2021

Primary completion

April 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

6 Months – 59 Months

Last updated February 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.